- Home
- LXRX vs VOR Comparison
LXRX vs VOR Comparison
Compare LXRX & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- VOR
- Stock Information
- Founded
- LXRX 1995
- VOR 2015
- Country
- LXRX United States
- VOR United States
- Employees
- LXRX N/A
- VOR N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- VOR Biotechnology: Pharmaceutical Preparations
- Sector
- LXRX Health Care
- VOR Health Care
- Exchange
- LXRX Nasdaq
- VOR Nasdaq
- Market Cap
- LXRX 124.4M
- VOR 134.8M
- IPO Year
- LXRX 2000
- VOR 2021
- Fundamental
- Price
- LXRX $0.46
- VOR $0.72
- Analyst Decision
- LXRX Buy
- VOR Strong Buy
- Analyst Count
- LXRX 4
- VOR 7
- Target Price
- LXRX $3.67
- VOR $9.43
- AVG Volume (30 Days)
- LXRX 30.7M
- VOR 269.5K
- Earning Date
- LXRX 03-06-2025
- VOR 03-20-2025
- Dividend Yield
- LXRX N/A
- VOR N/A
- EPS Growth
- LXRX N/A
- VOR N/A
- EPS
- LXRX N/A
- VOR N/A
- Revenue
- LXRX $31,081,000.00
- VOR N/A
- Revenue This Year
- LXRX N/A
- VOR N/A
- Revenue Next Year
- LXRX $101.91
- VOR N/A
- P/E Ratio
- LXRX N/A
- VOR N/A
- Revenue Growth
- LXRX 2481.48
- VOR N/A
- 52 Week Low
- LXRX $0.28
- VOR $0.63
- 52 Week High
- LXRX $2.45
- VOR $2.43
- Technical
- Relative Strength Index (RSI)
- LXRX 50.12
- VOR 28.48
- Support Level
- LXRX $0.32
- VOR $0.75
- Resistance Level
- LXRX $0.41
- VOR $0.93
- Average True Range (ATR)
- LXRX 0.05
- VOR 0.07
- MACD
- LXRX 0.03
- VOR 0.00
- Stochastic Oscillator
- LXRX 36.36
- VOR 7.61
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.